Table 4.

IgM ratios of Globo H analogs to Gb5 from breast cancer patients (n = 57) and healthy individuals (n = 47)

IgM ratio, %	GH/Gb5		Bb4/Gb5		Bb3/Gb5		Bb2/Gb5
	Healthy	Cancer	Healthy	Cancer	Healthy	Cancer	Healthy	Cancer
Mean	27.82	53.98	15.73	22.74	15.36	40.51	16.19	30.36
SD	23.42	35.41	21.60	23.98	23.30	59.76	18.83	35.44
P	P < 0.0001***		0.1259*		0.0043**		0.0105*

***, P < 0.001, extremely significant; **, P = 0.001–0.01, very significant; *, P = 0.01–0.05, significant.